Peptic ulcer disease: Clinically relevant causes and treatments

Orthopedics

Volumn 32, Issue 2, 2009, Pages 104-

  Mynatt, Ryan P ^a,b   Davis, George A ^a   Romanelli, Frank ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; BISMUTH SALICYLATE; CELECOXIB; CLARITHROMYCIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DICLOFENAC POTASSIUM; ESOMEPRAZOLE; HEXACYCLINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PARACETAMOL; PIROXICAM; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG;

ANALGESIA; ANTIBIOTIC RESISTANCE; BLEEDING; COMBINATION CHEMOTHERAPY; CYTOTOXICITY; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISULFIRAM LIKE REACTION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DYSPEPSIA; ENDOSCOPY; ENZYME INHIBITION; ERADICATION THERAPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HUMAN; INCIDENCE; NAUSEA; OSTEOARTHRITIS; PAIN; PEPTIC ULCER; PHOTOSENSITIVITY; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; STOMACH ULCER; TASTE DISORDER; TREATMENT OUTCOME; ULCER; ULCER HEALING; UPPER GASTROINTESTINAL BLEEDING; VOMITING; ARTICLE; CHEMICALLY INDUCED DISORDER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HELICOBACTER INFECTIONS; HUMANS; PEPTIC ULCER;

EID: 68149179804     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002; 54(3):320-326.
2. Mellemkjaer L, Blot WJ, Sorensen HT, et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol. 2002; 53(2):173-181. (Pubitemid 34264272)
3. Hernandez-Diaz S, Rodriguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. J Clin Epidemiol. 2002; 55(2):157-163. (Pubitemid 34051529)
4. Tarnawski A, Brzozowski T, Sarfeh IJ, et al. Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin. J Clin Invest. 1988; 81(4):1081-1089. (Pubitemid 18128071)
5. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008; 88(4):1547-1565.
6. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005; 129(5):1756-1780. (Pubitemid 41597412)
7. Zagari RM, Fuccio L, Bazzoli F. Investigating dyspepsia. BMJ. 2008; 337:a1400.
8. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390):1311-1315.
9. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter. 2008; 13(Suppl 1):1-6.
10. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev. 1991; (13):42-59.
11. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000; 181(4):1359-1363. (Pubitemid 30252540)
12. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102(8):1808-1825. (Pubitemid 47206706)
13. Midolo P, Marshall BJ. Accurate diagnosis of Helicobacter pylori. Urease tests. Gastroenterol Clin North Am. 2000; 29(4):871-878.
14. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002; 347(15):1175-1186.
15. Ho B, Marshall BJ. Accurate diagnosis of Helicobacter pylori. Serologic testing. Gastroenterol Clin North Am. 2000; 29(4):853-862.
16. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter. 2008; 13(Suppl 1):35-40.
17. Gisbert JP. "Rescue" regimens after Helicobacter pylori treatment failure. World J Gastroenterol. 2008; 14(35):5385-5402.
18. Gisbert JP, Bermejo F, Castro-Fernandez M, et al. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol. 2008; 103(1):71-76.
19. Chan FK, Sung JJ, Chung SC, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997; 350(9083):975-979.
20. De Leest HT, Steen KS, Bloemena E, et al. Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis: A Randomized Controlled Trial. J Clin Gastroenterol. Sep 12 2008.
21. Boparai V, Rajagopalan J, Triadafilopoulos G. Guide to the use of proton pump inhibitors in adult patients. Drugs. 2008; 68(7):925-947. (Pubitemid 351652922)
22. Amoxil (amoxicillin) prescribing information. May 2008. Available at us.gsk.com. Accessed: December 17, 2008.
23. Lexi-Comp Online Drug Information Database. Lexi-Comp 2008. Available at www.lexi.com. Accessed: December 17th, 2008.